Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Sevoflurane Coughing Frequency in Thyroidectomy
NCT06275425Completed
- Sponsor
- Yonsei University
- Start
- Jun 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remimazolam in thyroid neoplasm (2 arms), sponsored by Yonsei University. Primary endpoint: Proportion of patients not coughing during postoperative extubation. Started Jun 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
thyroid neoplasm
Beyond the preview
Go deeper on NCT06275425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06275425.